The integration of artificial intelligence (AI) has become an integral part of a large number of medical devices. AI supports diagnostics or provides medical professionals with decision-making aids for therapies and medication. Medical apps often only achieve full functionality through the use of AI. At the same time, however, the integration of AI components into medical devices also harbours risks that the European legislator wants to counter through sectoral and horizontal legal acts.
The alignment of the AI Regulation with the MDR/IVDR will be of particular relevance for medical device manufacturers, as the exciting field of self-learning, dynamic AI systems is not uniformly considered in the regulations. The simplifications provided for in the AI Regulation with regard to the (unnecessary) repeat conformity assessment procedure, which does not consider dynamic software adaptations to be a substantial change, do not benefit medical device manufacturers under the MDR and IVDR.
In this white paper, Miriam Schuh informs you about the special requirements of the AI Regulation for high-risk AI systems that go beyond the provisions of the MDR and IVDR.
You can download the full whitepaper here.
back